Brett Buller
Family Medicine · Dalton, OHNPI 1861709925
Payments from drug & device makers
Across 157 payments — averaging $16.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$570
- Pfizer$422
- Novo Nordisk$218
- GSK$183
- AbbVie$182
- Lilly USA, LLC$130
- plus $850 from 19 others
What the payments were for
- Food & beverage$2,555100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 7 | $570 |
| Pfizer | 43 | $422 |
| Novo Nordisk | 19 | $218 |
| GSK | 15 | $183 |
| AbbVie(2 entities) | 10 | $182 |
| Lilly USA, LLC | 8 | $130 |
| Johnson & Johnson | 6 | $99 |
| Boehringer Ingelheim | 6 | $93 |
| Amgen | 6 | $88 |
| Xeris Pharmaceuticals, Inc. | 4 | $72 |
| Bayer | 5 | $71 |
| Sanofi-aventis U.S. LLC | 5 | $71 |
| Astellas Pharma US Inc | 4 | $58 |
| Abbott | 3 | $54 |
| Merck | 3 | $38 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $33 |
| Exact Sciences | 2 | $32 |
| Dynavax Technologies Corporation | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $23 |
| Sanofi Pasteur Inc. | 1 | $19 |
| Vertex | 1 | $18 |
| Avanir Pharmaceuticals, Inc. | 1 | $17 |
| Dexcom, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,555 in reported general payments places this provider in the 75th percentile of 3,983 family medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 66 | $70,610 |
| EliquisApixaban | 89 | $67,062 |
| JardianceEmpagliflozin | 43 | $60,737 |
| XareltoRivaroxaban | 38 | $47,035 |
| FarxigaDapagliflozin Propanediol | 32 | $37,134 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 46 | $30,628 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 40 | $30,484 |
| OzempicSemaglutide | 19 | $29,454 |
| RybelsusSemaglutide | 20 | $19,598 |
| MounjaroTirzepatide | 11 | $19,074 |
| OxycontinOxycodone Hcl | 11 | $11,606 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 19 | $8,678 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 31 | $5,516 |
| SavellaMilnacipran Hcl | 11 | $5,167 |
| RestasisCyclosporine | 11 | $3,901 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $130 | $89,68377 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $570 | $67,61872 claims |
| PfizerEliquis | $422 | $67,06289 claims |
| Boehringer IngelheimJardiance | $93 | $60,73743 claims |
| Novo NordiskOzempic, Rybelsus | $218 | $49,05239 claims |
| Johnson & JohnsonXarelto | $99 | $47,03538 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $183 | $39,30665 claims |
| AbbVieSavella, Restasis, Synthroid | $182 | $10,70258 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Dalton
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
- Rajesh DavitCincinnati$2M
- Kwabena OtengSpringdale$2M
- Blaise GattoMoraine$1.8M
- Cathy GreiweColumbus$1.4M
- Brian BeesleyColumbus$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.